The Europe Sun
SEE OTHER BRANDS

The most trusted news from Europe

The Europe Sun: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.

Press releases published on May 6, 2025

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

BioAge Labs Reports First Quarter 2025 Financial Results and Provides Business Updates

Advancement of lead candidate BGE-102, an oral, brain-penetrant NLRP3 inhibitor for obesity, with initial clinical data expected 2H25 New strategic collaboration with Lilly ExploR…

MacroGenics Announces Date of First Quarter 2025 Financial Results

MacroGenics Announces Date of First Quarter 2025 Financial Results

ROCKVILLE, MD, May 06, 2025 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing, manufacturing and commercializing innovative monoclonal antibody-based therapeutics for the treatment of cancer, today …

DHT Holdings, Inc. First Quarter 2025 Results

DHT Holdings, Inc. First Quarter 2025 Results

HAMILTON, BERMUDA, May 6, 2025 – DHT Holdings, Inc. (NYSE:DHT) (“DHT” or the “Company”) today announced its results for the quarter ended March 31, 2025. The full report is available here and in the below attachment. About DHT Holdings, Inc. DHT is an …

Hyperlocal Grocery Delivery Market to Reach USD 111.3 Billion by 2035, Growing at a CAGR of 8.8% | FMI

Hyperlocal Grocery Delivery Market to Reach USD 111.3 Billion by 2035, Growing at a CAGR of 8.8% | FMI

Hyperlocal grocery delivery market is growing rapidly, driven by consumer demand for convenience, quick service, and digital ordering platforms. NEWARK, DE, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- The Hyperlocal Grocery Delivery market is set …

Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

Prelude Therapeutics Reports First Quarter 2025 Financial Results and Provides Corporate Update

PRT3789 monotherapy and combination with docetaxel escalation enrollment is complete and the Company plans to present updated results in the second half of 2025 Enrollment of the Phase 1 study of Prelude’s once daily, oral SMARCA2 degrader, PRT7732 is …

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

Keros Therapeutics Reports Recent First Quarter 2025 Financial Results

LEXINGTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients …

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

CRISPR Therapeutics Provides First Quarter 2025 Financial Results and Announces Positive Top-Line Data from Phase 1 Clinical Trial of CTX310™ Targeting ANGPTL3

-Initial CTX310™ Phase 1 clinical data demonstrates dose-dependent decreases in triglycerides (TG) and low-density lipoprotein (LDL), with peak reduction of up to 82% in TG and up to 81% in LDL, with a well-tolerated safety profile; presentation …

Day One Reports First Quarter 2025 Financial Results and Corporate Progress

Day One Reports First Quarter 2025 Financial Results and Corporate Progress

OJEMDA™ (tovorafenib) prescriptions grew 16% in Q1 2025 compared to Q4 2024 Achieved Q1 2025 OJEMDA™ (tovorafenib) net product revenue of $30.5 million Ended the first quarter with $473.0 million in cash, cash equivalents and short-term investments Company …

EXPERIENCE ON MAIN STREET – THE PIONEERING EXPERIENCE INDUSTRY CONFERENCE – RETURNS FOR ITS THIRD EDITION, THIS SUMMER

EXPERIENCE ON MAIN STREET – THE PIONEERING EXPERIENCE INDUSTRY CONFERENCE – RETURNS FOR ITS THIRD EDITION, THIS SUMMER

Experience on Main Street returns as a two day event uniting creative and business leaders to explore innovation, placemaking, and the future of experience. LONDON, UNITED KINGDOM, May 6, 2025 /⁨EINPresswire.com⁩/ -- After a critically acclaimed second …

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

Acumen Pharmaceuticals to Report First Quarter 2025 Financial Results on May 13, 2025

NEWTON, Mass., May 06, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS) (“Acumen” or the “Company”), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the …

Dimethyl Sulfoxide Market to Reach USD 968.4 Million by 2035, Driven by Eco-Friendly Solvent Demand and Innovation

Dimethyl Sulfoxide Market to Reach USD 968.4 Million by 2035, Driven by Eco-Friendly Solvent Demand and Innovation

The UK DMSO market is growing steadily, fueled by advances in pharmaceuticals, rising demand for green solvents, and expanding agrochemical use. NEWARK, DE, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- The Dimethyl Sulfoxide (DMSO) market is set to …

XRP News: Xp.Finance Sets New Standard For Decentralized Lending On The XRPL Ledger

XRP News: Xp.Finance Sets New Standard For Decentralized Lending On The XRPL Ledger

VILNIUS, Lithuania, May 06, 2025 (GLOBE NEWSWIRE) -- 2025 is poised to become the breakthrough year for XRP Ledger’s (XRPL) decentralized finance (DeFi) ecosystem. Amid renewed investor enthusiasm following the SEC’s landmark decision concluding its …

What Family-Owned Businesses Can Teach Us About Strategy That Big Corporations Often Miss

What Family-Owned Businesses Can Teach Us About Strategy That Big Corporations Often Miss

Luca Bertocci’s latest article reveals how family businesses execute strategy better—when top leadership drives quiet, decisive alignment. LONDON, GREATER LONDON, UNITED KINGDOM, May 6, 2025 /⁨EINPresswire.com⁩/ -- A new article is sparking conversations …

Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease

Late-Breaking Interim STENOVA Data Presented at Digestive Disease Week® 2025 Demonstrate Potential of AGMB-129 in Fibrostenosing Crohn’s Disease

Antwerp, Belgium, May 6, 2025 – Agomab Therapeutics NV (“Agomab”) today announced late-breaking interim data from the ongoing STENOVA1 Phase 2a clinical trial for AGMB-129, an oral gastro-intestinal (GI)-restricted small molecule inhibitor of ALK5 (TGF-β  …

Costamare Inc. Sets the Date for Its First Quarter 2025 Results Release, Conference Call and Webcast

Costamare Inc. Sets the Date for Its First Quarter 2025 Results Release, Conference Call and Webcast

Earnings Release: Thursday, May 8, 2025, Before Market Opens Conference Call and Webcast: Thursday, May 8, 2025, at 8:30 a.m. ET MONACO, May 06, 2025 (GLOBE NEWSWIRE) -- Costamare Inc. (NYSE:CMRE) (the “Company”), announced today that it will release its …

Northern Thai Capital, Chiang Mai Shines Selected Host City of 6 International Conferences in 2025

Northern Thai Capital, Chiang Mai Shines Selected Host City of 6 International Conferences in 2025

BANGKOK, THAILAND, May 6, 2025 /⁨EINPresswire.com⁩/ -- The northern Thai capital of Chiang Mai enhances its performances as a MICE destination when the city wins trust to host 6 international conferences in 2025 and makes another stride in securing at …

Digital Search Group Launches Full Service Digital Marketing Services for Law Firms

Digital Search Group Launches Full Service Digital Marketing Services for Law Firms

London, May 06, 2025 (GLOBE NEWSWIRE) -- Digital Search Group Limited, an innovator in technology, advertising and artificial intelligence is pleased to introduce its comprehensive digital marketing services for law firms. This strategi­c initiative is …

Trump boosts cryptocurrencies, XRP Mining opens up new opportunities for miners

Trump boosts cryptocurrencies, XRP Mining opens up new opportunities for miners

London, UK, May 06, 2025 (GLOBE NEWSWIRE) -- It is reported that Trump announced that a variety of digital assets including Bitcoin will be included in the new US cryptocurrency strategic reserve. This move has promoted the prosperity of the cryptocurrency …

Real-Time E-Healthcare System Market Poised for Significant Growth to Reach USD 64,362.0 Million by 2035 | FMI

Real-Time E-Healthcare System Market Poised for Significant Growth to Reach USD 64,362.0 Million by 2035 | FMI

Real-Time E-Healthcare System Market grows as demand surges for instant medical data access, remote monitoring, and smart health tech. NEWARK, DE, UNITED STATES, May 6, 2025 /⁨EINPresswire.com⁩/ -- The global real-time e-healthcare system market is on a …

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

Cosmos Health Receives Additional 180-Day Compliance Period from Nasdaq

CHICAGO, May 06, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company'') (NASDAQ:COSM), a diversified, vertically integrated global healthcare group engaged in innovative R…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service